Tonix Pharmaceuticals Logo

  • About
    • Leadership
      • Executive Team
      • Board of Directors
    • Facilities
  • Therapeutic Areas Overview
    • Central Nervous System
      • Fibromyalgia
      • Migraine
    • Infectious Disease
      • Lyme Disease
      • Mpox (Monkey Pox)
      • Smallpox
    • Immunology and Immuno-oncology
      • Organ Transplant Rejection
      • Gastro-Intestinal Cancers
    • Rare Disease
      • Prader-Willi Syndrome
  • Pipeline
    • Central Nervous System
      • TNX-102 SL
      • TNX-1300
    • Infectious Disease
      • TNX-4800
      • TNX-801
      • TNX-4200 CD45
    • Immunology and Immuno-oncology
      • TNX-1500
      • TNX-1700
      • TNX-4700
    • Rare Disease
      • TNX-2900
    • Expanded Access Policy
  • Medicines
  • Clinical
    • Clinical Trials
    • Adverse Event Reporting
    • Submit a Grant Proposal
    • Submit a Research Proposal
    • Pain Guides
      • Fibromyalgia Pain Guide
      • Migraine Pain Guide
  • News & Events
    • Press Releases
    • Investor Presentations
    • Scientific Presentations
    • IR Events
    • Op-eds
  • Investors
    • News & Events
    • Presentations
      • Investor Presentations
      • Scientific Presentations
      • Program Specific Presentations
      • Conference Materials
    • Multimedia
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact Us

IR Events

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Events
    • Email Alerts
    • Op-Eds
  • Presentations
  • Multimedia
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • Form 8937
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

  • News & Events

  • Press Releases
  • IR Events
  • Email Alerts
  • Op-Eds

Second Quarter 2026 Financial Results

Aug 10, 2026 8:30 am EDT
Earnings Release
PDF HTML
Earnings Webcast
Audio
10-Q Filing
PDF HTML
XBRL
ZIP HTML
2Q'26 Call Presentation
PDF
email icon Sign up for Email Alerts
twitter icon linkedin icon facebook icon
  • Compliance
  • Privacy Policy
  • Terms of Service
  • Site Map

© 2026 Tonix Pharmaceuticals Holding Corp.